查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1539675

内分泌胜肽检测2024年全球市场报告

Endocrine Peptide Test Global Market Report 2024
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10个工作天内

价格
简介目录

内分泌胜肽检测市场规模预计在未来几年将强劲成长。 2028年将以9.4%的年复合成长率（CAGR）成长至130.3亿美元。预测期内的增长是由于内分泌胜肽检测需求的增加、研发的扩大、文明病的增加、老年人口的迅速增加以及普通人群中糖尿病患病率的上升。预计这段时期的主要趋势包括内分泌检测方法的进步、产品技术的改进、旨在开发创新检测解决方案的研发活动的活性化、产品核可的增加以及对预防性医疗保健的关注度的增加等。

糖尿病盛行率的增加预计将推动内分泌胜肽检测市场的成长。糖尿病以血糖值升高为特征，由于不良的饮食习惯、久坐的生活方式、遗传倾向和衰老等因素，糖尿病的发生率正在上升。血红蛋白 A1c、空腹血糖和 C胜肽测试等内分泌胜肽测试在诊断糖尿病、监测血糖浓度以及评估胰岛素产生和敏感性方面发挥重要作用。例如，2021年，国际糖尿病联盟报告称，全球约有5.37亿20岁至79岁的成年人患有糖尿病。预计到 2030 年，这一数字将增至 6.43 亿，到 2045 年将增至 7.83 亿，凸显了糖尿病盛行率驱动的市场成长轨迹。

内分泌胜肽检测市场的主要企业正在开发提高准确性、灵敏度和速度的免疫检测检测系统。这些系统使用抗体来检测和量化血液和尿液样本中的特定胜胜肽，为医疗保健专业人员提供有关荷尔蒙水平和内分泌功能的重要见解。例如，2023 年 7 月，西门子 Healthineers 推出了 Atellica CI 分析仪，这是一种紧凑型系统，能够进行免疫测量和临床化学测试，包括内分泌胜肽测定。我们的生殖内分泌菜单包括用于评估卵巢储备功能的抗苗勒氏管激素 (AMH) 以及用于妊娠毒血症预后的 sFlt-1 和 PlGF 等测试。 Atellica CI 分析仪每小时能够进行多达 1000 次测试，可提供快速、一致、高品质的结果，帮助实验室满足不断变化的测试需求。

目录

第一章执行摘要

第二章 市场特点

第三章 市场趋势与策略

第四章宏观经济情景

  • 高通膨对市场的影响
  • 乌克兰与俄罗斯战争对市场的影响
  • COVID-19 对市场的影响

第五章世界市场规模与成长

  • 全球内分泌胜胜肽检测市场：驱动因素与抑制因素
    • 市场驱动因素
    • 市场限制因素
  • 全球内分泌胜肽检测市场表现：规模和成长，2018-2023
  • 全球内分泌胜胜肽检测市场预测：规模与成长，2023-2028、2033

第六章 市场细分

  • 全球内分泌胜胜肽检测市场：依检测类型分類的表现与预测，2018-2023、2023-2028、2033
  • 硫酸脱氢表雄酮
  • 黄体酮
  • 黄体激素
  • 甲状腺催乳素
  • 雌二醇
  • 人类绒毛膜促性腺激素分泌
  • 甲状腺刺激素
  • 其他测试类型
  • 全球内分泌胜胜肽检测市场：依技术、效能和预测划分，2018-2023年、2023-2028年、2033年
  • 质谱分析
  • 免疫检测
  • 层析法
  • 基于核酸的
  • 其他技术
  • 全球内分泌胜肽检测市场：按最终用户、性能和预测，2018-2023、2023-2028、2033
  • 诊所
  • 保健中心
  • 医院
  • 商业研究所

第 7 章 区域/国家分析

  • 全球内分泌胜胜肽检测市场：按地区、绩效和预测，2018-2023、2023-2028、2033
  • 全球内分泌胜胜肽检测市场：依国家、绩效及预测，2018-2023年、2023-2028年、2033年

第八章亚太市场

第九章 中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第14章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章 义大利市场

第20章 西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章加拿大市场

第26章 南美洲市场

第27章 巴西市场

第28章 中东市场

第29章 非洲市场

第三十章 竞争格局及公司概况

  • 内分泌胜胜肽检测市场：竞争格局
  • 内分泌胜胜肽检测市场：公司简介
    • Siemens AG
    • F. Hoffmann-La Roche AG
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • Becton Dickinson and Company

第三十一章 其他重大及创新企业

  • Laboratory Corporation of America Holdings（LabCorp）
  • Quest Diagnostics Incorporated
  • Agilent Technologies Inc.
  • Illumina Inc.
  • bioMerieux SA
  • Bio-Rad Laboratories Inc.
  • DiaSorin SpA
  • Sciex
  • Bio-Techne Corporation
  • Invitae Corporation
  • ARUP Laboratories
  • Genova Diagnostics
  • Boston Heart Diagnostics Corporation
  • Immunodiagnostic Systems Ltd.
  • Mayo Clinic Laboratories

第32章竞争基准化分析

第 33 章. 竞争对手仪表板

第三十四章 重大併购

第35章前瞻性与潜力分析

第36章附录

简介目录
Product Code: r19114

The endocrine peptide test is a diagnostic procedure used to assess levels of specific peptides in blood or urine, crucial for monitoring the endocrine system's function and detecting related disorders. It primarily focuses on measuring peptide hormones in blood to diagnose and track endocrine disorders.

Key tests in the endocrine peptide market include dehydroepiandrosterone sulfate (DHEAS), progesterone, luteinizing hormone, thyroid prolactin, estradiol, human chorionic gonadotropin, thyroid-stimulating hormone, among others. The DHEAS test specifically measures DHEAS levels in the bloodstream. Technologies employed include mass spectroscopy, immunoassay, chromatography, nucleic acid-based methods, and others. End users include clinics, healthcare centers, hospitals, and commercial laboratories.

The endocrine peptide test market research report is one of a series of new reports from The Business Research Company that provides endocrine peptide test market statistics, including the endocrine peptide test industry global market size, regional shares, competitors with endocrine peptide test market share, detailed endocrine peptide test market segments, market trends, and opportunities, and any further data you may need to thrive in the endocrine peptide test industry. These endocrine peptide test market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The endocrine peptide test market size has grown strongly in recent years. It will grow from $8.34 billion in 2023 to $9.11 billion in 2024 at a compound annual growth rate (CAGR) of 9.2%. The increase during the historic period was driven by higher government expenditure, a growing incidence of diabetes, declining immunity levels globally, heightened risk of chronic diseases, and increased governmental initiatives.

The endocrine peptide test market size is expected to see strong growth in the next few years. It will grow to $13.03 billion in 2028 at a compound annual growth rate (CAGR) of 9.4%. Anticipated growth in the forecast period will stem from rising demand for endocrine peptide tests, expansion in research and development efforts, an uptick in lifestyle diseases, a burgeoning elderly population, and a rising prevalence of diabetes among the general populace. Key trends expected in this period include advancements in endocrine testing methodologies, improvements in product technologies, increased R&D activities aimed at developing innovative testing solutions, a rise in product approvals, and a shift towards preventive healthcare.

The increasing prevalence of diabetes is expected to drive growth in the endocrine peptide test market. Diabetes, characterized by elevated blood sugar levels, is on the rise due to factors such as poor diets, sedentary lifestyles, genetic predisposition, and an aging population. Endocrine peptide tests such as hemoglobin A1c, fasting plasma glucose, and C-peptide tests play a crucial role in diagnosing diabetes, monitoring glucose levels, and evaluating insulin production and sensitivity. For instance, in 2021, the International Diabetes Federation reported that approximately 537 million adults aged 20-79 were living with diabetes globally. This number is projected to increase to 643 million by 2030 and 783 million by 2045, highlighting the market's growth trajectory driven by diabetes prevalence.

Leading companies in the endocrine peptide test market are advancing immunoassay testing systems to enhance accuracy, sensitivity, and speed. These systems employ antibodies to detect and quantify specific peptides in blood or urine samples, providing healthcare professionals with essential insights into hormone levels and endocrine function. For example, Siemens Healthineers introduced the Atellica CI Analyzer in July 2023, a compact system capable of immunoassay and clinical chemistry testing, including endocrine peptide assays. It features a reproductive endocrinology menu with tests such as anti-Mullerian hormone (AMH) for ovarian reserve assessment and sFlt-1 and PlGF for preeclampsia prognosis. With a capacity of up to 1000 tests per hour, the Atellica CI Analyzer ensures rapid and consistent delivery of high-quality results, supporting laboratories in meeting evolving testing demands.

In October 2022, Tolmar, a US-based pharmaceutical company, acquired Jatenzo from Clarus Therapeutics to bolster its portfolio in pediatric endocrinology and men's health. Jatenzo, a testosterone replacement therapy, complements Tolmar's specialty pharmaceutical products, enhancing their offerings for individuals with endocrine disorders. Clarus Therapeutics, known for developing therapies in this field, facilitated the acquisition, expanding Tolmar's market presence and therapeutic capabilities.

Major companies operating in the endocrine peptide test market are Siemens AG, F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Merck KGaA, Becton Dickinson and Company, Laboratory Corporation of America Holdings (LabCorp), Quest Diagnostics Incorporated, Agilent Technologies Inc., Illumina Inc., bioMerieux SA, Bio-Rad Laboratories Inc., DiaSorin S.p.A., Sciex, Bio-Techne Corporation, Invitae Corporation, ARUP Laboratories, Genova Diagnostics, Boston Heart Diagnostics Corporation, Immunodiagnostic Systems Ltd., Mayo Clinic Laboratories

North America was the largest region in the endocrine peptide test market in 2023. The regions covered in the endocrine peptide test market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the endocrine peptide test market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The endocrine peptide test market includes revenues earned by entities by providing services such as diagnostic testing, laboratory analysis, research studies, and clinical evaluations. The market value includes the value of related goods sold by the service provider or included within the service offering. The endocrine peptide test market also includes sales of diagnostic kits, reagents, testing instruments, and laboratory equipment. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Endocrine Peptide Test Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on endocrine peptide test market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for endocrine peptide test ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The endocrine peptide test market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Test-Type: Dehydroepiandrosterone Sulphate; Progesterone; Luteinizing Hormone; Thyroid Prolactin; Oestradiol; Human Chorionic Gonadotropin; Thyroid-Stimulating Hormone; Other Test-Types
  • 2) By Technology: Mass Spectroscopy; Immunoassay; Chromatography; Nucleic Acid Based; Other Technologies
  • 3) By End-User: Clinics; Healthcare Centers; Hospitals; Commercial Laboratories
  • Companies Mentioned: Siemens AG; F. Hoffmann-La Roche AG; Thermo Fisher Scientific Inc.; Merck KGaA; Becton Dickinson and Company
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Endocrine Peptide Test Market Characteristics

3. Endocrine Peptide Test Market Trends And Strategies

4. Endocrine Peptide Test Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Endocrine Peptide Test Market Size and Growth

  • 5.1. Global Endocrine Peptide Test Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Endocrine Peptide Test Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Endocrine Peptide Test Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Endocrine Peptide Test Market Segmentation

  • 6.1. Global Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Dehydroepiandrosterone Sulphate
  • Progesterone
  • Luteinizing Hormone
  • Thyroid Prolactin
  • Oestradiol
  • Human Chorionic Gonadotropin
  • Thyroid-Stimulating Hormone
  • Other Test-Types
  • 6.2. Global Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Mass Spectroscopy
  • Immunoassay
  • Chromatography
  • Nucleic Acid Based
  • Other Technologies
  • 6.3. Global Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Clinics
  • Healthcare Centers
  • Hospitals
  • Commercial Laboratories

7. Endocrine Peptide Test Market Regional And Country Analysis

  • 7.1. Global Endocrine Peptide Test Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Endocrine Peptide Test Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Endocrine Peptide Test Market

  • 8.1. Asia-Pacific Endocrine Peptide Test Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Endocrine Peptide Test Market

  • 9.1. China Endocrine Peptide Test Market Overview
  • 9.2. China Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Endocrine Peptide Test Market

  • 10.1. India Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Endocrine Peptide Test Market

  • 11.1. Japan Endocrine Peptide Test Market Overview
  • 11.2. Japan Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Endocrine Peptide Test Market

  • 12.1. Australia Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Endocrine Peptide Test Market

  • 13.1. Indonesia Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Endocrine Peptide Test Market

  • 14.1. South Korea Endocrine Peptide Test Market Overview
  • 14.2. South Korea Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Endocrine Peptide Test Market

  • 15.1. Western Europe Endocrine Peptide Test Market Overview
  • 15.2. Western Europe Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Endocrine Peptide Test Market

  • 16.1. UK Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Endocrine Peptide Test Market

  • 17.1. Germany Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Endocrine Peptide Test Market

  • 18.1. France Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Endocrine Peptide Test Market

  • 19.1. Italy Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Endocrine Peptide Test Market

  • 20.1. Spain Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Endocrine Peptide Test Market

  • 21.1. Eastern Europe Endocrine Peptide Test Market Overview
  • 21.2. Eastern Europe Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Endocrine Peptide Test Market

  • 22.1. Russia Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Endocrine Peptide Test Market

  • 23.1. North America Endocrine Peptide Test Market Overview
  • 23.2. North America Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Endocrine Peptide Test Market

  • 24.1. USA Endocrine Peptide Test Market Overview
  • 24.2. USA Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Endocrine Peptide Test Market

  • 25.1. Canada Endocrine Peptide Test Market Overview
  • 25.2. Canada Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Endocrine Peptide Test Market

  • 26.1. South America Endocrine Peptide Test Market Overview
  • 26.2. South America Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Endocrine Peptide Test Market

  • 27.1. Brazil Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Endocrine Peptide Test Market

  • 28.1. Middle East Endocrine Peptide Test Market Overview
  • 28.2. Middle East Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Endocrine Peptide Test Market

  • 29.1. Africa Endocrine Peptide Test Market Overview
  • 29.2. Africa Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Endocrine Peptide Test Market Competitive Landscape And Company Profiles

  • 30.1. Endocrine Peptide Test Market Competitive Landscape
  • 30.2. Endocrine Peptide Test Market Company Profiles
    • 30.2.1. Siemens AG
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. F. Hoffmann-La Roche AG
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Thermo Fisher Scientific Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Merck KGaA
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Becton Dickinson and Company
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Endocrine Peptide Test Market Other Major And Innovative Companies

  • 31.1. Laboratory Corporation of America Holdings (LabCorp)
  • 31.2. Quest Diagnostics Incorporated
  • 31.3. Agilent Technologies Inc.
  • 31.4. Illumina Inc.
  • 31.5. bioMerieux SA
  • 31.6. Bio-Rad Laboratories Inc.
  • 31.7. DiaSorin S.p.A.
  • 31.8. Sciex
  • 31.9. Bio-Techne Corporation
  • 31.10. Invitae Corporation
  • 31.11. ARUP Laboratories
  • 31.12. Genova Diagnostics
  • 31.13. Boston Heart Diagnostics Corporation
  • 31.14. Immunodiagnostic Systems Ltd.
  • 31.15. Mayo Clinic Laboratories

32. Global Endocrine Peptide Test Market Competitive Benchmarking

33. Global Endocrine Peptide Test Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Endocrine Peptide Test Market

35. Endocrine Peptide Test Market Future Outlook and Potential Analysis

  • 35.1 Endocrine Peptide Test Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Endocrine Peptide Test Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Endocrine Peptide Test Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer